GE Healthcare AS markets contrast agent for x-ray, ultrasound, Magnetic Resonance Imaging, and radiopharmaceuticals for clinicians to predict, diagnose, inform, and treat diseases. The company was founded on September 07, 1981 and it is headquartered in Oslo, Norway.

FutureChem Co., Ltd. engages in the manufacture of medical products. Its products include radiopharmaceutical, automation module, chemicals, linkers (bioconjugation), ionic liquids and custom synthesis. In addition, it also engages in the research and development of radioisotope labeling. The company was founded on August 13, 2001 and is headquartered in Seoul, South Korea.

Regents of The University of Michigan provides administers bonds on behalf of the University. The company is headquartered in Ann Arbor, MI.

Non-Invasive Monitoring Systems, Inc. currently operates as a shell company. The company was founded by Marvin A. Sackner on July 16, 1980 and is headquartered in Miami, FL.

Sonus Pharmaceuticals, Inc. engaged in the development of drugs for the treatment of cancer and related therapies. Its primary product TOCOSOL Paclitaxel, was an injectable paclitaxel emulsion for nonsmall cell lung cancer, ovarian cancer and bladder cancer. Sonus Pharmaceuticals was incorporated in 1991 and was headquartered in Bothell, WA.

GENESIS Pharma started its activity in pharmaceutical biotechnology in 1997, at a time when the industry was still at an early development stage, not only in Greece but also in Europe. The company's goal was to combine the rapid progress in science with a successful and innovative business venture, thus paving the way for the creation of a new market. Working with consistency and dedication to this end, GENESIS Pharma became the first Greek pharmaceutical company specializing in the promotion, sales and distribution of biopharmaceutical products and is currently the largest by turnover among Greek companies focusing on innovative branded medicines. The company’s portfolio consists mainly of innovative pharmaceutical products in the therapeutic areas of Oncology, Hematology, Central Nervous System, Inflammation and Immunology, Gastroenterology and Nephrology, as a result of collaboration with major multinational pharmaceutical companies. Among its partners are two of the biggest, based on market capitalization, companies focusing on the research and development of novel pharmaceutical products, Biogen and Celgene.

B.C.B. International Ltd. is a private company headquartered in Cardiff, UK, also operating in US. The firm designs, manufactures, supplies protective equipment. It was founded in 1854 by - Brown. Andrew Howell is the current CEO of the company.\nAn excerpt from the company's website reads as follows: Since its creation in 1854, BCB International has been developing pioneering innovations that have helped generations of armed forces personnel, seafarers, aid workers and adventurers operate and survive in some of the world’s harshest environments.

Founded in 1993 by Andrew Cousin, Amersham Corp. is a private equity firm located in Louisville, Colorado with additional offices in California, Florida, Texas and China.

ZEON Corp. engages in the production and sale of synthetic rubbers and specialty plastics. It operates through the following segments: Elastomer Materials Business, Specialty Materials Business, and Others. The Elastomer Materials Business segment includes synthetic rubbers used in automobile tires and conveyer belts; synthetic lattices used in tires and adhesives; and chemical products such as resins and inks. The Specialty Materials Business segment comprises of synthetic aroma chemicals and other industrial chemicals; information and imaging materials; specialty plastics for optical lenses; and medical products. The Others segment consists of paints, butadiene extraction technology, and reaction injection molding (RIM) formulations and products. The company was founded on April 12, 1950 and is headquartered in Tokyo, Japan.

Part of Boston Scientific Corp., EndoVascular Technologies, Inc. is a company headquartered in Menlo Park, CA, that makes invasive endovascular systems. The firm was founded by Wesley D. Sterman. Guidant Corp. acquired EndoVascular Technologies, Inc. on December 22, 1997 for $145.32 million.

ZOLL Medical Corp. develops and markets medical devices and related software solutions for emergency care. It provides products for defibrillation and monitoring, circulation and CPR feedback, data management, fluid resuscitation, and therapeutic temperature management. The firm provides technologies which help fire professionals, clinicians, and rescuers in providing critical care and resuscitation treatment. It also designs software that automates data documentation and management for both clinical and non-clinical information. The company was founded by William Bright, Rolf S. Stutz, Paul M. Zoll, Leigh Stein, and Thomas M. Claflin in 1980 and is headquartered in Chelmsford, MA.

Part of LifeTech Scientific Corp., Lifetech Scientific (Shenzhen) Co. Ltd. is a Chinese company located in Shenzhen that manufactures medical devices. On July 06, 2004 ATC Technology Corp. (Arizona) acquired Lifetech Scientific (Shenzhen) Co. Ltd.

CritiSense was founded in 2004 on the basis of the assets of an earlier company named Vital Medical. The company's device, the Critiview, was developed by the company's co-founder and chief scientist, Professor Avraham Mayevsky, formerly head of the department of Department of Life Sciences and Dean of the Faculty of Natural Sciences at Bar Ilan University, where he established a center for tissue physiology. It provides continuous, real-time multi-parametric physiological data at the tissue and cellular level, by monitoring the mitochondrial function and the microcirculatory blood flow and oxygen saturation, by way of tissue titration therapy with an optical sensor.

Part of NFM Group AS, Hexonia GmbH is a company headquartered in Nettetal, Germany. The firm manufactures combat cloths. It was founded in 2005. Gerd Hexels is the current CEO of the firm. NFM Group AS acquired Hexonia GmbH on December 16, 2022.

Wuhan McCorzine Biotechnology Co., Ltd., established on 2018-01-09, Business scope includes technology development in the field of biotechnology,technology transfer,technical consulting;Biotechnology Testing Services;laboratory reagent(Does not contain dangerous goods),laboratory consumables,plastic products,Instrumentation,electronic product(Does not include electronic publications)wholesale and retail;one,R&D of Class II medical devices,and leasing;Import and export,Technology Import and Export,Agent import and export(Does not contain goods or technologies that are prohibited or restricted from import and export by the state).(Projects subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Kodenshi Corp. manufactures and sells semiconductor devices and develops electronic appliances. Its products include Lighting, Back Light & Illumination LED; Silicon Product; Opto semiconductor element; Sensor/Opto component/module; and Group company products. It also offers the following solutions: IT Solution, Digital Home Appliance, Office Automation, Amusement, Robot, Automobile, Lighting, and Lighting for Plants. The company was founded in May 1972 and is headquartered in Uji, Japan.

Nippon Zeon Co., Ltd., part of BASF SE, is a company headquartered in Tokyo, Japan. The firm manufactures speciality liquid resins. It was acquired by Ciba Holding AG on March 01, 1998.

Advanced Circulatory Systems manufactures and markets intrathoracic pressure regulation products to help restore life and improve the quality of life for patients experiencing cardiac arrest, low blood pressure, and head injury. Advanced Circulatory Systems serves military, emergency medical services, and hospital markets and the company’s products are sold in over 25 countries worldwide.

The University of California is the nation's best public university system, delivering top-notch research and innovation to California (and the world).